Ask about this productRelated genes to: Guf1 Blocking Peptide
- Gene:
- GUF1 NIH gene
- Name:
- GUF1 homolog, GTPase
- Previous symbol:
- -
- Synonyms:
- FLJ13220
- Chromosome:
- 4p12
- Locus Type:
- gene with protein product
- Date approved:
- 2006-02-14
- Date modifiied:
- 2016-10-05
Related products to: Guf1 Blocking Peptide
Related articles to: Guf1 Blocking Peptide
- Decades of intensive breeding for rapid growth rate has resulted in increased abdominal fat content in commercial broilers, which also led to significant economic loss in this industry. In the present study, we integrated RNA-Seq datasets of 44 samples, including 22 fat- and 22 lean-line, to identify the selection signatures linked to abdominal fat content in chickens. - Source: PubMed
Publication date: 2025/11/27
Abbasabadi HosseinBakhtiarizadeh Mohammad RezaMansourizadeh HosseinGutiérrez-Gil Beatriz - Eukaryotic elongation factor 1 alpha 2 (eEF1A2) is a protein coding gene which is involved in tumor development and progression in several types of human cancer, but little is known about the function of eEF1A2 proteins in gastric cancer (GC). This study aimed to investigate the effects of , and on the migration of GC cells. - Source: PubMed
Publication date: 2024/09/27
Ma HaixiuSuo LinaZhao JingMa RonghuaWang QiLiu JunQiao JinwanWu JuanAn JuanLiu YanXing YonghuaWang HaiyanSu Zhanhai - Gastric cancer (GC) is a highly aggressive malignancy with a heterogeneous nature, which makes prognosis prediction and treatment determination difficult. Inflammation is now recognized as one of the hallmarks of cancer and plays an important role in the aetiology and continued growth of tumours. Inflammation also affects the prognosis of GC patients. Recent reports suggest that a number of inflammatory-related biomarkers are useful for predicting tumour prognosis. However, the importance of inflammatory-related biomarkers in predicting the prognosis of GC patients is still unclear. - Source: PubMed
Hu Jia-LiHuang Mei-JinHalina HalikeQiao KunWang Zhi-YuanLu Jia-JieYin Cheng-LiangGao Feng - Childhood epilepsy is a common neurological disorder with a prevalence of 300-600 cases per 100,000 people. It is associated with refractory epilepsies, global developmental delay, and epileptic encephalopathies, causing epileptic syndromes characterized by cognitive and behavioral disorders. - Source: PubMed
Publication date: 2023/10/09
Bariş SavaşKırık SerkanBalasar Özgür - Postsynthetic modification of metal-organic frameworks (MOFs) has proven to be a hugely powerful tool to tune physical properties and introduce functionality, by exploiting reactive sites on both the MOF linkers and their inorganic secondary building units (SBUs), and so has facilitated a wide range of applications. Studies into the reactivity of MOF SBUs have focussed solely on removal of neutral coordinating solvents, or direct exchange of linkers such as carboxylates, despite the prevalence of ancillary charge-balancing oxide and hydroxide ligands found in many SBUs. Herein, we show that the μ-OH ligands in the MIL-53 topology Sc MOF, GUF-1, are labile, and can be substituted for μ-OCH units through reaction with pore-bound methanol molecules in a very rare example of pressure-induced postsynthetic modification. Using comprehensive solid-state NMR spectroscopic analysis, we show an order of magnitude increase in this cluster anion substitution process after exposing bulk samples suspended in methanol to a pressure of 0.8 GPa in a large volume press. Additionally, single crystals compressed in diamond anvil cells with methanol as the pressure-transmitting medium have enabled full structural characterisation of the process across a range of pressures, leading to a quantitative single-crystal to single-crystal conversion at 4.98 GPa. This unexpected SBU reactivity - in this case chemisorption of methanol - has implications across a range of MOF chemistry, from activation of small molecules for heterogeneous catalysis to chemical stability, and we expect cluster anion substitution to be developed into a highly convenient novel method for modifying the internal pore surface and chemistry of a range of porous materials. - Source: PubMed
Publication date: 2023/06/19
Thom Alexander J RTurner Gemma FDavis Zachary HWard Martin RPakamorė IgnasHobday Claire LAllan David RWarren Mark RLeung Wai L WOswald Iain D HMorris Russell EMoggach Stephen AAshbrook Sharon EForgan Ross S